Cencora, Inc. (LON:0HF3)
London · Delayed Price · Currency is GBP · Price in USD 344.38
+4.66 (1.37%)
At close: Dec 19, 2025
Cencora Market Cap
Cencora has a market cap or net worth of 49.33 billion as of December 19, 2025. Its market cap has increased by 29.22% in one year.
Market Cap
49.33B
Enterprise Value
53.22B
Revenue
239.05B
Ranking
n/a
PE Ratio
42.66
Stock Price
344.38
Market Cap Chart
Since April 4, 1995, Cencora's market cap has increased from 199.85M to 49.33B, an increase of 24,581.62%. That is a compound annual growth rate of 19.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 49.32B | 42.19% |
| Dec 31, 2024 | 34.69B | 8.10% |
| Dec 29, 2023 | 32.09B | 15.46% |
| Dec 30, 2022 | 27.79B | 36.06% |
| Dec 31, 2021 | 20.43B | 39.67% |
| Dec 31, 2020 | 14.62B | 10.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.44B |
| GSK plc | 73.06B |
| Haleon | 32.37B |
| Smith & Nephew | 10.25B |
| Convatec Group | 4.58B |
| Hikma Pharmaceuticals | 3.34B |
| HUTCHMED (China) | 1.73B |
| Genus | 1.70B |